Long-Term Disease Control With Lenvatinib in Metastatic Malignant Struma Ovarii: A Case Report

Ryota Kawano1, Tomoko Sumikura2, Kohki Shimazu3

  • 1Otolaryngology - Head and Neck Surgery, Osaka General Medical Center, Osaka, JPN.

Cureus
|December 1, 2025
PubMed
Summary

Malignant struma ovarii, a rare ovarian tumor, can be treated long-term with lenvatinib (LVB) for metastatic disease. This therapy showed potential for sustained tumor control, even with dose adjustments and interruptions.